News
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

157,521 Results

Type

Article (6402)
Company Profile (56)
Press Release (151063)

Section

Business (56193)
Career Advice (167)
Deals (11506)
Drug Delivery (9)
Drug Development (20377)
Employer Resources (22)
FDA (3519)
Job Trends (3523)
News (88995)
Policy (6745)

Tag

Date

Today (15)
Last 7 days (184)
Last 30 days (426)
Last 365 days (9791)
2024 (5552)
2023 (10009)
2022 (11970)
2021 (31695)
2020 (19918)
2019 (10088)
2018 (7140)
2017 (6709)
2016 (5809)
2015 (7089)
2014 (4812)
2013 (3602)
2012 (3801)
2011 (4407)
2010 (4362)

Filters

Type

Article (6402)
Company Profile (56)
Press Release (151063)

Section

Business (56193)
Career Advice (167)
Deals (11506)
Drug Delivery (9)
Drug Development (20377)
Employer Resources (22)
FDA (3519)
Job Trends (3523)
News (88995)
Policy (6745)

Tag

Date

Today (15)
Last 7 days (184)
Last 30 days (426)
Last 365 days (9791)
2024 (5552)
2023 (10009)
2022 (11970)
2021 (31695)
2020 (19918)
2019 (10088)
2018 (7140)
2017 (6709)
2016 (5809)
2015 (7089)
2014 (4812)
2013 (3602)
2012 (3801)
2011 (4407)
2010 (4362)

157,521 Results for "22".

Sort By

Lifecore Biomedical Announces Cooperation Agreement with 22NW

Lifecore Biomedical, Inc. announced it has reached a cooperation agreement with 22NW, LP, which provides for the addition of Humberto Antunes, Jason Aryeh, Paul Johnson and Matthew Korenberg to the Board of Directors of the Company effective immediately following the 2023 Annual Meeting of Stockholders.

July 1, 2024
·
10 min read
Business

Medpace Holdings, Inc. to Report Second Quarter 2024 Financial Results on July 22, 2024

Medpace Holdings, Inc. announced that it will report its second quarter 2024 financial results after the market close on Monday, July 22, 2024.

June 26, 2024
·
1 min read
Genetown

GENFIT: May 22, 2024 Combined Shareholders Meeting Results

GENFIT, a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, announced the results of the Combined Shareholders Meeting which took place on May 22, 2024.

May 22, 2024
·
4 min read
Business

Evotec SE to Announce Results for First Quarter 2024 on 22 May 2024

Evotec SE will announce its financial results for the first quarter of 2024 on Wednesday, 22 May 2024.

May 15, 2024
·
3 min read
Genetown

Scholar Rock to Host Investor Day on May 22, 2024

Scholar Rock today announced it will host an Investor Day on Wednesday, May 22, 2024 beginning at 8:30 a.m. ET in New York City.

May 14, 2024
·
3 min read
BioMidwest

Assertio to Participate in Benchmark Healthcare Conference on May 21-22

Assertio Holdings, Inc. announced that Ajay Patel, Chief Financial Officer, will host investor meetings as part of the Benchmark & Company Healthcare House Call Virtual Conference, taking place May 21-22, 2024.

May 17, 2024
·
2 min read
Business

NANOBIOTIX to Announce First Quarter Operational and Financial Update on May 22, 2024

NANOBIOTIX announced that it will report its financial and operational results for the first quarter of 2024 on May 22, 2024, before the US and EU markets open.

May 15, 2024
·
2 min read
Deals

CONMED Corporation Announces Quarterly Cash Dividend - May 22, 2024

CONMED Corporation (NYSE: CNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on May 22, 2024, payable on July 5, 2024, to all shareholders of record as of June 14, 2024.

May 22, 2024
·
1 min read
Business

NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024

NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS) will report summarized financial results for its first quarter 2024, for the period ended March 31, 2024, on Wednesday, May 22, 2024, before market open.

May 15, 2024
·
3 min read
Influenza Vaccine Market is Forecasted to Worth US$ 22.71 Billion By 2032

The global influenza vaccine market was valued at US$ 8.78 billion in 2023. The global market is projected to hit the market valuation of US$ 22.71 billion by 2032, growing at a CAGR of 11.07% during the forecast period from 2024 to 2032.

April 29, 2024
·
7 min read

1 of 15,753

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
Hotbeds
About
More

© 1985 - 2024 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin